Due to manufacturing constraints, we unfortunately anticipate temporary stock shortage of Estradot TTS-75. At the moment, we expect delays to stock from April 9, with supplies returning to normal levels within approximately 8 weeks.
We understand shortages such as these can cause great uncertainty for patients and we are working hard to resolve this matter as quickly as possible. We encourage any patient affected by this shortage to speak with their doctor or pharmacist for information on available options.
Supplies of Estradot TTS-25, Estradot TTS-50 and Estradot TTS-100 are unaffected.
If you are a healthcare professional and would like further information, please contact the Novartis Pharmaceuticals UK Medical Information Services by email; [email protected] or by phone; +44 1276 698370